Savara
SVRA
#6423
Rank
NZ$1.61 B
Marketcap
NZ$7.87
Share price
-6.12%
Change (1 day)
24.87%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -NZ$0.25 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.22 Billion a decrease over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.25 Billion15.3%
2025 -NZ$0.22 Billion23.94%
2024 -NZ$0.17 Billion75.29%
2023 -NZ$96.74 Million43.38%
2022 -NZ$67.47 Million-11.31%
2021 -NZ$76.08 Million-13.3%
2020 -NZ$87.75 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.13 Billion105.54%
2017 -NZ$59.13 Million34.11%
2016 -NZ$44.09 Million-37.43%
2015 -NZ$70.47 Million38.81%
2014 -NZ$50.76 Million33.62%
2013 -NZ$37.99 Million38.49%
2012 -NZ$27.44 Million24.59%
2011 -NZ$22.02 Million-36.5%
2010 -NZ$34.68 Million-3.14%
2009 -NZ$35.8 Million-23.28%
2008 -NZ$46.66 Million8.52%
2007 -NZ$43 Million-34.14%
2006 -NZ$65.29 Million184.43%
2005 -NZ$22.96 Million90.75%
2004 -NZ$12.04 Million190.35%
2003 -NZ$4.15 Million11.64%
2002 -NZ$3.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion-42.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.11 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA